Jeffrey Bronstein, PhD - Publications

Affiliations: 
University of California, Los Angeles, Los Angeles, CA 

95 high-probability publications. We are testing a new system for linking publications to authors. You can help! If you notice any inaccuracies, please sign in and mark papers as correct or incorrect matches. If you identify any major omissions or other inaccuracies in the publication list, please let us know.

Year Citation  Score
2015 Bronstein JM, Paul K, Yang L, Haas RH, Shults CW, Le T, Ritz B. Platelet mitochondrial activity and pesticide exposure in early Parkinson's disease. Movement Disorders : Official Journal of the Movement Disorder Society. 30: 862-6. PMID 25757798 DOI: 10.1002/mds.26164  0.56
2015 Lee PC, Bordelon Y, Bronstein J, Sinsheimer JS, Farrer M, Ritz B. Head injury, α-synuclein genetic variability and Parkinson's disease. European Journal of Neurology : the Official Journal of the European Federation of Neurological Societies. 22: 874-8. PMID 25370538 DOI: 10.1111/ene.12585  0.56
2015 Rothlind JC, York MK, Carlson K, Luo P, Marks WJ, Weaver FM, Stern M, Follett K, Reda D. Neuropsychological changes following deep brain stimulation surgery for Parkinson's disease: comparisons of treatment at pallidal and subthalamic targets versus best medical therapy. Journal of Neurology, Neurosurgery, and Psychiatry. 86: 622-9. PMID 25185211 DOI: 10.1136/jnnp-2014-308119  0.56
2015 Bronstein JM, Tagliati M, McIntyre C, Chen R, Cheung T, Hargreaves EL, Israel Z, Moffitt M, Montgomery EB, Stypulkowski P, Shils J, Denison T, Vitek J, Volkman J, Wertheimer J, et al. The rationale driving the evolution of deep brain stimulation to constant-current devices. Neuromodulation : Journal of the International Neuromodulation Society. 18: 85-8; discussion 88-. PMID 25171762 DOI: 10.1111/ner.12227  0.56
2014 Bronstein JM, Fitzmaurice A. Author response. Neurology. 83: 1879-80. PMID 25544982  0.56
2014 Koppel BS, Brust JC, Fife T, Bronstein J, Youssof S, Gronseth G, Gloss D. Systematic review: efficacy and safety of medical marijuana in selected neurologic disorders: report of the Guideline Development Subcommittee of the American Academy of Neurology. Neurology. 82: 1556-63. PMID 24778283 DOI: 10.1212/WNL.0000000000000363  0.56
2014 O'Donnell KC, Lulla A, Stahl MC, Wheat ND, Bronstein JM, Sagasti A. Axon degeneration and PGC-1α-mediated protection in a zebrafish model of α-synuclein toxicity. Disease Models & Mechanisms. 7: 571-82. PMID 24626988 DOI: 10.1242/dmm.013185  0.56
2014 Liew Z, Wang A, Bronstein J, Ritz B. Job exposure matrix (JEM)-derived estimates of lifetime occupational pesticide exposure and the risk of Parkinson's disease. Archives of Environmental & Occupational Health. 69: 241-51. PMID 24499252 DOI: 10.1080/19338244.2013.778808  0.56
2014 Fitzmaurice AG, Rhodes SL, Cockburn M, Ritz B, Bronstein JM. Aldehyde dehydrogenase variation enhances effect of pesticides associated with Parkinson disease. Neurology. 82: 419-26. PMID 24491970 DOI: 10.1212/WNL.0000000000000083  0.56
2014 Wang A, Cockburn M, Ly TT, Bronstein JM, Ritz B. The association between ambient exposure to organophosphates and Parkinson's disease risk. Occupational and Environmental Medicine. 71: 275-81. PMID 24436061 DOI: 10.1136/oemed-2013-101394  0.56
2014 Rhodes SL, Buchanan DD, Ahmed I, Taylor KD, Loriot MA, Sinsheimer JS, Bronstein JM, Elbaz A, Mellick GD, Rotter JI, Ritz B. Pooled analysis of iron-related genes in Parkinson's disease: association with transferrin. Neurobiology of Disease. 62: 172-8. PMID 24121126 DOI: 10.1016/j.nbd.2013.09.019  0.56
2013 Narayan S, Liew Z, Paul K, Lee PC, Sinsheimer JS, Bronstein JM, Ritz B. Household organophosphorus pesticide use and Parkinson's disease. International Journal of Epidemiology. 42: 1476-85. PMID 24057998 DOI: 10.1093/ije/dyt170  0.56
2013 Rhodes SL, Fitzmaurice AG, Cockburn M, Bronstein JM, Sinsheimer JS, Ritz B. Pesticides that inhibit the ubiquitin-proteasome system: effect measure modification by genetic variation in SKP1 in Parkinson׳s disease. Environmental Research. 126: 1-8. PMID 23988235 DOI: 10.1016/j.envres.2013.08.001  0.56
2013 Lee PC, Rhodes SL, Sinsheimer JS, Bronstein J, Ritz B. Functional paraoxonase 1 variants modify the risk of Parkinson's disease due to organophosphate exposure. Environment International. 56: 42-7. PMID 23602893 DOI: 10.1016/j.envint.2013.03.004  0.56
2013 Fitzmaurice AG, Rhodes SL, Lulla A, Murphy NP, Lam HA, O'Donnell KC, Barnhill L, Casida JE, Cockburn M, Sagasti A, Stahl MC, Maidment NT, Ritz B, Bronstein JM. Aldehyde dehydrogenase inhibition as a pathogenic mechanism in Parkinson disease. Proceedings of the National Academy of Sciences of the United States of America. 110: 636-41. PMID 23267077 DOI: 10.1073/pnas.1220399110  0.56
2012 Lee PC, Bordelon Y, Bronstein J, Ritz B. Traumatic brain injury, paraquat exposure, and their relationship to Parkinson disease. Neurology. 79: 2061-6. PMID 23150532 DOI: 10.1212/WNL.0b013e3182749f28  0.56
2012 Weaver FM, Follett KA, Stern M, Luo P, Harris CL, Hur K, Marks WJ, Rothlind J, Sagher O, Moy C, Pahwa R, Burchiel K, Hogarth P, Lai EC, Duda JE, ... ... Bronstein JM, et al. Randomized trial of deep brain stimulation for Parkinson disease: thirty-six-month outcomes. Neurology. 79: 55-65. PMID 22722632 DOI: 10.1212/WNL.0b013e31825dcdc1  0.56
2012 Ritz B, Rhodes SL, Bordelon Y, Bronstein J. α-Synuclein genetic variants predict faster motor symptom progression in idiopathic Parkinson disease. Plos One. 7: e36199. PMID 22615757 DOI: 10.1371/journal.pone.0036199  0.56
2012 Prabhudesai S, Sinha S, Attar A, Kotagiri A, Fitzmaurice AG, Lakshmanan R, Lakshmanan R, Ivanova MI, Loo JA, Klärner FG, Schrader T, Stahl M, Bitan G, Bronstein JM. A novel "molecular tweezer" inhibitor of α-synuclein neurotoxicity in vitro and in vivo. Neurotherapeutics : the Journal of the American Society For Experimental Neurotherapeutics. 9: 464-76. PMID 22373667 DOI: 10.1007/s13311-012-0105-1  0.56
2012 Chan N, Le C, Shieh P, Mozaffar T, Khare M, Bronstein J, Kimonis V. Valosin-containing protein mutation and Parkinson's disease. Parkinsonism & Related Disorders. 18: 107-9. PMID 21816654 DOI: 10.1016/j.parkreldis.2011.07.006  0.56
2011 Bordelon YM, Hays RD, Vassar SD, Diaz N, Bronstein J, Vickrey BG. Medication responsiveness of motor symptoms in a population-based study of Parkinson disease. Parkinson's Disease. 2011: 967839. PMID 22191067 DOI: 10.4061/2011/967839  0.56
2011 Wang A, Costello S, Cockburn M, Zhang X, Bronstein J, Ritz B. Parkinson's disease risk from ambient exposure to pesticides. European Journal of Epidemiology. 26: 547-55. PMID 21505849 DOI: 10.1007/s10654-011-9574-5  0.56
2011 Rosenbloom B, Balwani M, Bronstein JM, Kolodny E, Sathe S, Gwosdow AR, Taylor JS, Cole JA, Zimran A, Weinreb NJ. The incidence of Parkinsonism in patients with type 1 Gaucher disease: data from the ICGG Gaucher Registry. Blood Cells, Molecules & Diseases. 46: 95-102. PMID 21067946 DOI: 10.1016/j.bcmd.2010.10.006  0.56
2011 Rhodes SL, Sinsheimer JS, Bordelon Y, Bronstein JM, Ritz B. Replication of GWAS associations for GAK and MAPT in Parkinson's disease. Annals of Human Genetics. 75: 195-200. PMID 21058943 DOI: 10.1111/j.1469-1809.2010.00616.x  0.56
2010 Gatto NM, Rhodes SL, Manthripragada AD, Bronstein J, Cockburn M, Farrer M, Ritz B. α-Synuclein gene may interact with environmental factors in increasing risk of Parkinson's disease. Neuroepidemiology. 35: 191-5. PMID 20664293 DOI: 10.1159/000315157  0.56
2010 Follett KA, Weaver FM, Stern M, Hur K, Harris CL, Luo P, Marks WJ, Rothlind J, Sagher O, Moy C, Pahwa R, Burchiel K, Hogarth P, Lai EC, Duda JE, ... ... Bronstein JM, et al. Pallidal versus subthalamic deep-brain stimulation for Parkinson's disease. The New England Journal of Medicine. 362: 2077-91. PMID 20519680 DOI: 10.1056/NEJMoa0907083  0.56
2010 Chou AP, Li S, Fitzmaurice AG, Bronstein JM. Mechanisms of rotenone-induced proteasome inhibition. Neurotoxicology. 31: 367-72. PMID 20417232 DOI: 10.1016/j.neuro.2010.04.006  0.56
2010 Costello S, Bordelon Y, Bronstein J, Ritz B. Familial associations of Alzheimer disease and essential tremor with Parkinson disease. European Journal of Neurology : the Official Journal of the European Federation of Neurological Societies. 17: 871-8. PMID 20236304 DOI: 10.1111/j.1468-1331.2010.02974.x  0.56
2010 Manthripragada AD, Costello S, Cockburn MG, Bronstein JM, Ritz B. Paraoxonase 1, agricultural organophosphate exposure, and Parkinson disease. Epidemiology (Cambridge, Mass.). 21: 87-94. PMID 19907334 DOI: 10.1097/EDE.0b013e3181c15ec6  0.56
2010 Plaitakis A, Latsoudis H, Kanavouras K, Ritz B, Bronstein JM, Skoula I, Mastorodemos V, Papapetropoulos S, Borompokas N, Zaganas I, Xiromerisiou G, Hadjigeorgiou GM, Spanaki C. Gain-of-function variant in GLUD2 glutamate dehydrogenase modifies Parkinson's disease onset. European Journal of Human Genetics : Ejhg. 18: 336-41. PMID 19826450 DOI: 10.1038/ejhg.2009.179  0.56
2009 Gatto NM, Cockburn M, Bronstein J, Manthripragada AD, Ritz B. Well-water consumption and Parkinson's disease in rural California. Environmental Health Perspectives. 117: 1912-8. PMID 20049211 DOI: 10.1289/ehp.0900852  0.56
2009 Farag ES, Vinters HV, Bronstein J. Pathologic findings in retinal pigment epithelial cell implantation for Parkinson disease. Neurology. 73: 1095-102. PMID 19726750 DOI: 10.1212/WNL.0b013e3181bbff1c  0.56
2009 Ritz BR, Manthripragada AD, Costello S, Lincoln SJ, Farrer MJ, Cockburn M, Bronstein J. Dopamine transporter genetic variants and pesticides in Parkinson's disease. Environmental Health Perspectives. 117: 964-9. PMID 19590691 DOI: 10.1289/ehp.0800277  0.56
2009 Costello S, Cockburn M, Bronstein J, Zhang X, Ritz B. Parkinson's disease and residential exposure to maneb and paraquat from agricultural applications in the central valley of California. American Journal of Epidemiology. 169: 919-26. PMID 19270050 DOI: 10.1093/aje/kwp006  0.56
2009 Bronstein J, Carvey P, Chen H, Cory-Slechta D, DiMonte D, Duda J, English P, Goldman S, Grate S, Hansen J, Hoppin J, Jewell S, Kamel F, Koroshetz W, Langston JW, et al. Meeting report: consensus statement-Parkinson's disease and the environment: collaborative on health and the environment and Parkinson's Action Network (CHE PAN) conference 26-28 June 2007. Environmental Health Perspectives. 117: 117-21. PMID 19165397 DOI: 10.1289/ehp.11702  0.56
2009 Weaver FM, Follett K, Stern M, Hur K, Harris C, Marks WJ, Rothlind J, Sagher O, Reda D, Moy CS, Pahwa R, Burchiel K, Hogarth P, Lai EC, Duda JE, ... ... Bronstein J, et al. Bilateral deep brain stimulation vs best medical therapy for patients with advanced Parkinson disease: a randomized controlled trial. Jama. 301: 63-73. PMID 19126811 DOI: 10.1001/jama.2008.929  0.56
2008 Chou AP, Maidment N, Klintenberg R, Casida JE, Li S, Fitzmaurice AG, Fernagut PO, Mortazavi F, Chesselet MF, Bronstein JM. Ziram causes dopaminergic cell damage by inhibiting E1 ligase of the proteasome. The Journal of Biological Chemistry. 283: 34696-703. PMID 18818210 DOI: 10.1074/jbc.M802210200  0.56
2008 Wahner AD, Bronstein JM, Bordelon YM, Ritz B. Statin use and the risk of Parkinson disease. Neurology. 70: 1418-22. PMID 18184918 DOI: 10.1212/01.wnl.0000286942.14552.51  0.56
2008 Ritz B, Wahner AD, Bordelon Y, Bronstein JM. Can anti-inflammatory agents protect against Parkinson's disease? Future Neurology. 3: 107-111. DOI: 10.2217/14796708.3.2.107  0.56
2007 Wahner AD, Bronstein JM, Bordelon YM, Ritz B. Nonsteroidal anti-inflammatory drugs may protect against Parkinson disease. Neurology. 69: 1836-42. PMID 17984451 DOI: 10.1212/01.wnl.0000279519.99344.ad  0.56
2007 Wahner AD, Sinsheimer JS, Bronstein JM, Ritz B. Inflammatory cytokine gene polymorphisms and increased risk of Parkinson disease. Archives of Neurology. 64: 836-40. PMID 17562931 DOI: 10.1001/archneur.64.6.836  0.56
2007 Wahner AD, Glatt CE, Bronstein JM, Ritz B. Glutathione S-transferase mu, omega, pi, and theta class variants and smoking in Parkinson's disease. Neuroscience Letters. 413: 274-8. PMID 17194543 DOI: 10.1016/j.neulet.2006.11.053  0.56
2006 Bronstein JM, Chou AP. Peripheral proteasome and caspase activity in Parkinson disease and Alzheimer disease [1] Neurology. 67: 182. PMID 16832113 DOI: 10.1212/01.wnl.0000229918.11244.7a  0.56
2006 Wang XF, Li S, Chou AP, Bronstein JM. Inhibitory effects of pesticides on proteasome activity: Implication in Parkinson's disease Neurobiology of Disease. 23: 198-205. PMID 16626962 DOI: 10.1016/j.nbd.2006.02.012  0.56
2006 Tiwari-Woodruff S, Beltran-Parrazal L, Charles A, Keck T, Vu T, Bronstein J. K+ channel KV3.1 associates with OSP/claudin-11 and regulates oligodendrocyte development. American Journal of Physiology. Cell Physiology. 291: C687-98. PMID 16624990 DOI: 10.1152/ajpcell.00510.2005  0.56
2006 Bhidayasiri R, Bronstein JM, Cohen MS, Shellock FG. Response to Letter to the Editor Magnetic Resonance Imaging. 24: 679-680. DOI: 10.1016/j.mri.2005.12.002  0.56
2005 Diaz N, Bronstein JM. Parkinson's Disease Research Education and Clinical Centers (PADRECC): Background and overview Neurorehabilitation. 20: 153-160. PMID 16340096  0.56
2005 Follett K, Weaver F, Stern M, Marks W, Hogarth P, Holloway K, Bronstein J, Duda J, Horn S, Lai E, Samii A, Okun MS, Foote KD. Multisite randomized trial of deep brain stimulation [4] (multiple letters) Archives of Neurology. 62: 1643-1645. PMID 16216957  0.56
2005 Kang GA, Bronstein JM, Masterman DL, Redelings M, Crum JA, Ritz B. Clinical characteristics in early Parkinson's disease in a central California population-based study Movement Disorders. 20: 1133-1142. PMID 15954133 DOI: 10.1002/mds.20513  0.56
2005 Bhidayasiri R, Bronstein JM, Sinha S, Krahl SE, Ahn S, Behnke EJ, Cohen MS, Frysinger R, Shellock FG. Bilateral neurostimulation systems used for deep brain stimulation: in vitro study of MRI-related heating at 1.5 T and implications for clinical imaging of the brain. Magnetic Resonance Imaging. 23: 549-55. PMID 15919600 DOI: 10.1016/j.mri.2005.02.007  0.56
2005 Chow E, Mottahedeh J, Prins M, Ridder W, Nusinowitz S, Bronstein JM. Disrupted compaction of CNS myelin in an OSP/Claudin-11 and PLP/DM20 double knockout mouse Molecular and Cellular Neuroscience. 29: 405-413. PMID 15886014 DOI: 10.1016/j.mcn.2005.03.007  0.56
2005 Ostrem JL, Kang GA, Subramanian I, Guarnieri M, Hubble J, Rabinowicz AL, Bronstein J. The effect of entacapone on homocysteine levels in Parkinson disease Neurology. 64: 1482. PMID 15851757  0.56
2005 Bhidayasiri R, Bronstein JM. Improvement of cervical dystonia: Possible role of transcranial magnetic stimulation simulating sensory tricks effect Medical Hypotheses. 64: 941-945. PMID 15780489 DOI: 10.1016/j.mehy.2004.11.022  0.56
2005 Lee MWY, De Salles AAF, Frighetto L, Torres R, Behnke E, Bronstein JM. Deep brain stimulation in intraoperative MRI environment - Comparison of imaging techniques and electrode fixation methods Minimally Invasive Neurosurgery. 48: 1-6. PMID 15747209 DOI: 10.1055/s-2004-830169  0.56
2005 Bhidayasiri R, Miyata H, Bronstein JM, Schweitzer J, Saber PA, Vinters HV. Postmortem analysis of pallidotomy in Parkinson's disease. Journal of Neurology. 252: 100-2. PMID 15654563 DOI: 10.1007/s00415-005-0593-6  0.56
2004 Tiwari-Woodruff SK, Myers LW, Bronstein JM. Cerebrospinal fluid immunoglobulin G promotes oligodendrocyte progenitor cell migration Journal of Neuroscience Research. 77: 363-366. PMID 15248292 DOI: 10.1002/jnr.20178  0.56
2004 Tiwari-Woodruff SK, Kaplan R, Kornblum HI, Bronstein JM. Developmental expression of OAP-1/Tspan-3, a member of the tetraspanin superfamily. Journal of Neuroscience Research. 77: 166-73. PMID 15211584 DOI: 10.1002/jnr.20141  0.56
2004 Kang GA, Bronstein JM. Psychosis in nursing home patients with parkinson's disease Journal of the American Medical Directors Association. 5: 167-173. PMID 15115577  0.56
2003 Bryant JA, De Salles A, Cabatan C, Frysinger R, Behnke E, Bronstein J. The impact of thalamic stimulation on activities of daily living for essential tremor. Surgical Neurology. 59: 479-84; discussion 4. PMID 12826348 DOI: 10.1016/S0090-3019(03)00091-0  0.56
2003 Sage JR, Anagnostaras SG, Mitchell S, Bronstein JM, De Salles A, Masterman D, Knowlton BJ. Analysis of probabilistic classification learning in patients with Parkinson's disease before and after pallidotomy surgery. Learning & Memory (Cold Spring Harbor, N.Y.). 10: 226-36. PMID 12773587 DOI: 10.1101/lm.45903  0.56
2003 Nutt JG, Burchiel KJ, Comella CL, Jankovic J, Lang AE, Laws ER, Lozano AM, Penn RD, Simpson RK, Stacy M, Wooten GF. Randomized, double-blind trial of glial cell line-derived neurotrophic factor (GDNF) in PD. Neurology. 60: 69-73. PMID 12525720  0.56
2002 Subramanian I, Vanek ZF, Bronstein JM. Diagnosis and treatment of Wilson's disease Current Neurology and Neuroscience Reports. 2: 317-323. PMID 12044251  0.56
2002 Liau LM, Jensen ER, Kremen TJ, Odesa SK, Sykes SN, Soung MC, Miller JF, Bronstein JM. Tumor immunity within the central nervous system stimulated by recombinant Listeria monocytogenes vaccination. Cancer Research. 62: 2287-93. PMID 11956085  0.56
2001 Myers LW, Ellison GW, Mendoza F, Bronstein JM. T-cell responses to oligodendrocyte-specific protein in multiple sclerosis Journal of Neuroscience Research. 66: 506-509. PMID 11746369 DOI: 10.1002/jnr.1241  0.56
2001 Tiwari-Woodruff SK, Buznikov AG, Vu TQ, Micevych PE, Chen K, Kornblum HI, Bronstein JM. OSP/claudin-11 forms a complex with a novel member of the tetraspanin super family and beta1 integrin and regulates proliferation and migration of oligodendrocytes. The Journal of Cell Biology. 153: 295-305. PMID 11309411 DOI: 10.1083/jcb.153.2.295  0.56
2001 Intemann PM, Masterman D, Subramanian I, DeSalles A, Behnke E, Frysinger R, Bronstein JM. Staged bilateral pallidotomy for treatment of Parkinson disease. Journal of Neurosurgery. 94: 437-44. PMID 11235949 DOI: 10.3171/jns.2001.94.3.0437  0.56
2000 Liau LM, Black KL, Martin NA, Sykes SN, Bronstein JM, Jouben-Steele L, Mischel PS, Belldegrun A, Cloughesy TF. Treatment of a patient by vaccination with autologous dendritic cells pulsed with allogeneic major histocompatibility complex class I-matched tumor peptides. Case Report. Neurosurgical Focus. 9: e8. PMID 16817691  0.56
2000 Bronstein JM. Function of tetraspan proteins in the myelin sheath Current Opinion in Neurobiology. 10: 552-557. PMID 11084316 DOI: 10.1016/S0959-4388(00)00125-2  0.56
2000 Bronstein JM, Chen K, Tiwari-Woodruff S, Kornblum HI. Developmental expression of OSP/claudin-11. Journal of Neuroscience Research. 60: 284-90. PMID 10797530 DOI: 10.1002/(SICI)1097-4547(20000501)60:3<284::AID-JNR2>3.0.CO;2-T  0.56
2000 Liau LM, Lallone RL, Seitz RS, Buznikov A, Gregg JP, Kornblum HI, Nelson SF, Bronstein JM. Identification of a human glioma-associated growth factor gene, granulin, using differential immuno-absorption. Cancer Research. 60: 1353-60. PMID 10728698  0.56
2000 Bronstein JM, Tiwari-Woodruff S, Buznikov AG, Stevens DB. Involvement of OSP/claudin-11 in oligodendrocyte membrane interactions: Role in biology and disease Journal of Neuroscience Research. 59: 706-711. PMID 10700007 DOI: 10.1002/(SICI)1097-4547(20000315)59:6<706::AID-JNR2>3.0.CO;2-D  0.56
1999 Gow A, Southwood CM, Li JS, Pariali M, Riordan GP, Brodie SE, Danias J, Bronstein JM, Kachar B, Lazzarini RA. CNS myelin and sertoli cell tight junction strands are absent in Osp/claudin-11 null mice. Cell. 99: 649-59. PMID 10612400  0.56
1999 Bronstein JM, DeSalles A, DeLong MR. Stereotactic pallidotomy in the treatment of Parkinson disease: an expert opinion. Archives of Neurology. 56: 1064-9. PMID 10488806 DOI: 10.1001/archneur.56.9.1064  0.56
1999 Bronstein JM, Lallone RL, Seitz RS, Ellison GW, Myers LW. A humoral response to oligodendrocyte-specific protein in MS: A potential molecular mimic Neurology. 53: 154-161. PMID 10408552  0.56
1999 Stevens DB, Chen K, Seitz RS, Sercarz EE, Bronstein JM. Oligodendrocyte-specific protein peptides induce experimental autoimmune encephalomyelitis in SJL/J mice Journal of Immunology. 162: 7501-7509. PMID 10358205  0.56
1999 Liau LM, Black KL, Prins RM, Sykes SN, DiPatre PL, Cloughesy TF, Becker DP, Bronstein JM. Treatment of intracranial gliomas with bone marrow-derived dendritic cells pulsed with tumor antigens. Journal of Neurosurgery. 90: 1115-24. PMID 10350260 DOI: 10.3171/jns.1999.90.6.1115  0.56
1998 Masterman D, DeSalles A, Baloh RW, Frysinger R, Foti D, Behnke E, Cabatan-Awang C, Hoetzel A, Intemann PM, Fairbanks L, Bronstein JM. Motor, cognitive, and behavioral performance following unilateral ventroposterior pallidotomy for Parkinson disease. Archives of Neurology. 55: 1201-8. PMID 9740114 DOI: 10.1001/archneur.55.9.1201  0.56
1998 Slovin SF, Scher HI, Divgi CR, Reuter V, Sgouros G, Moore M, Weingard K, Pettengall R, Imbriaco M, El-Shirbiny A, Finn R, Bronstein J, Brett C, Milenic D, Dnistrian A, et al. Interferon-γ and monoclonal antibody 131I-labeled CC49: Outcomes in patients with androgen-independent prostate cancer Clinical Cancer Research. 4: 643-651. PMID 9533532  0.56
1998 Bronstein JM, Hales TG, Tyndale RF, Charles AC. A conditionally immortalized glial cell line that expresses mature myelin proteins and functional GABA(A) receptors. Journal of Neurochemistry. 70: 483-91. PMID 9453541  0.56
1997 Bronstein JM, Micevych PE, Chen K. Oligodendrocyte-specific protein (OSP) is a major component of CNS myelin. Journal of Neuroscience Research. 50: 713-20. PMID 9418959 DOI: 10.1002/(SICI)1097-4547(19971201)50:5<713::AID-JNR8>3.0.CO;2-K  0.56
1997 Lim JY, De Salles AAF, Bronstein J, Masterman DL, Saver JL. Delayed internal capsule infarctions following radiofrequency pallidotomy. Report of three cases Journal of Neurosurgery. 87: 955-960. PMID 9384411  0.56
1997 Kornblum HI, Hussain RJ, Bronstein JM, Gall CM, Lee DC, Seroogy KB. Prenatal ontogeny of the epidermal growth factor receptor and its ligand, transforming growth factor alpha, in the rat brain. The Journal of Comparative Neurology. 380: 243-61. PMID 9100135 DOI: 10.1002/(SICI)1096-9861(19970407)380:2<243::AID-CNE7>3.0.CO;2-3  0.56
1997 Popper P, Farber DB, Micevych PE, Minoofar K, Bronstein JM. TRPM-2 expression and tunel staining in neurodegenerative diseases: studies in wobbler and rd mice. Experimental Neurology. 143: 246-54. PMID 9056387 DOI: 10.1006/exnr.1996.6364  0.56
1996 Bronstein JM, Yamashita C, Farber DB. Exclusion of the β-subunit of type II calmodulin kinase for the wobbler spinal muscular atrophy gene Molecular Brain Research. 43: 330-332. PMID 9037549 DOI: 10.1016/S0169-328X(96)00045-9  0.56
1996 Bronstein JM, Popper P, Micevych PE, Farber DB. Isolation and characterization of a novel oligodendrocyte-specific protein. Neurology. 47: 772-8. PMID 8797478  0.56
1996 Bronstein JM, Kozak CA, Chen XN, Wu S, Danciger M, Korenberg JR, Farber DB. Chromosomal localization of murine and human oligodendrocyte-specific protein genes. Genomics. 34: 255-7. PMID 8661061 DOI: 10.1006/geno.1996.0278  0.56
1996 Hurtig HI, Stern M, Colcher A, Simon SR, Baringer JR, De Salles AAF, Bronstein J, Masterman D, Sagman DL, Dvorak HF, Salzman EW. Living with Parkinson's disease [1] New England Journal of Medicine. 335: 130-131. PMID 8649476 DOI: 10.1056/NEJM199607113350212  0.56
1993 Bronstein JM, Farber DB, Wasterlain CG. Regulation of type-II calmodulin kinase: functional implications. Brain Research. Brain Research Reviews. 18: 135-47. PMID 8385527 DOI: 10.1016/0165-0173(93)90011-N  0.56
1992 Wasterlain CG, Bronstein JM, Morin AM, Dwyer BE, Sankar R. Translocation and autophosphorylation of brain calmodulin kinase II in status epilepticus. Epilepsy Research. Supplement. 9: 231-8. PMID 1337440  0.56
1992 Bronstein JM, Micevych P, Popper P, Huez G, Farber DB, Wasterlain CG. Long-lasting decreases of type II calmodulin kinase expression in kindled rat brains. Brain Research. 584: 257-60. PMID 1325246 DOI: 10.1016/0006-8993(92)90903-M  0.56
1990 Bronstein JM, Farber DB, Micevych PE, Lasher R, Wasterlain CG. Kindling induced changes in calmodulin kinase II immunoreactivity. Brain Research. 524: 49-53. PMID 2169328 DOI: 10.1016/0006-8993(90)90490-3  0.56
1989 Bronstein J, Wasterlain CG, Lasher R, Farber DB. Dark-induced changes in activity and compartmentalization of retinal calmodulin kinase in the rat. Brain Research. 495: 83-8. PMID 2550112 DOI: 10.1016/0006-8993(89)91220-1  0.56
1988 Bronstein JM, Wasterlain CG, Bok D, Lasher R, Farber DB. Localization of retinal calmodulin kinase. Experimental Eye Research. 47: 391-402. PMID 2846334 DOI: 10.1016/0014-4835(88)90050-4  0.56
1988 Bronstein J, Farber D, Wasterlain C. Decreased calmodulin kinase activity after status epilepticus. Neurochemical Research. 13: 83-6. PMID 2835695 DOI: 10.1007/BF00971859  0.56
1988 Bronstein J, Nishimura R, Lasher R, Cole R, de Vellis J, Farber D, Wasterlain C. Calmodulin kinase II in pure cultured astrocytes. Journal of Neurochemistry. 50: 45-9. PMID 2826689  0.56
Show low-probability matches.